Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 1
1984 1
1985 4
1986 2
1987 4
1988 5
1989 8
1990 7
1991 8
1992 6
1993 3
1994 17
1995 5
1996 10
1997 10
1998 18
1999 10
2000 17
2001 5
2002 11
2003 16
2004 17
2005 25
2006 22
2007 24
2008 12
2009 17
2010 16
2011 18
2012 14
2013 18
2014 19
2015 18
2016 19
2017 21
2018 25
2019 22
2020 19
2021 29
2022 19
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

505 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Lupus anticoagulant disorder"
Page 1
Diagnosis and management of the antiphospholipid syndrome.
Chaturvedi S, McCrae KR. Chaturvedi S, et al. Blood Rev. 2017 Nov;31(6):406-417. doi: 10.1016/j.blre.2017.07.006. Epub 2017 Jul 30. Blood Rev. 2017. PMID: 28784423 Free PMC article. Review.
Laboratory diagnosis of APLA depends upon the detection of a lupus anticoagulant, which prolongs phospholipid-dependent anticoagulation tests, and/or anticardiolipin (aCL) and anti-beta2-glycoprotein-1 (beta2GPI) antibodies. ...There is a high rate of recurrent thro …
Laboratory diagnosis of APLA depends upon the detection of a lupus anticoagulant, which prolongs phospholipid-dependent antico …
Antiphospholipid syndrome.
Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Ruiz-Irastorza G, et al. Lancet. 2010 Oct 30;376(9751):1498-509. doi: 10.1016/S0140-6736(10)60709-X. Epub 2010 Sep 6. Lancet. 2010. PMID: 20822807 Review.
Complement activation might have a central pathogenetic role. Of the different antiphospholipid antibodies, lupus anticoagulant is the strongest predictor of features related to antiphospholipid syndrome. ...Possible future therapies for non-pregnant patients …
Complement activation might have a central pathogenetic role. Of the different antiphospholipid antibodies, lupus anticoagulant …
Lupus Nephritis and Pregnancy: Concerns and Management.
Lightstone L, Hladunewich MA. Lightstone L, et al. Semin Nephrol. 2017 Jul;37(4):347-353. doi: 10.1016/j.semnephrol.2017.05.006. Semin Nephrol. 2017. PMID: 28711073 Free article. Review.
Even with quiescent disease, recent data indicate that being lupus anticoagulant-positive, nonwhite or Hispanic, and using antihypertensive medications were all predictors of worse pregnancy outcomes. Further, prior lupus nephritis also predi …
Even with quiescent disease, recent data indicate that being lupus anticoagulant-positive, nonwhite or Hispanic, and us …
Diagnosis and management of catastrophic antiphospholipid syndrome.
Carmi O, Berla M, Shoenfeld Y, Levy Y. Carmi O, et al. Expert Rev Hematol. 2017 Apr;10(4):365-374. doi: 10.1080/17474086.2017.1300522. Epub 2017 Mar 13. Expert Rev Hematol. 2017. PMID: 28277850 Review.
Catastrophic antiphospholipid syndrome (CAPS) is a rare, life-threatening disease. In 1992, Asherson defined it as a widespread coagulopathy related to the antiphospholipid antibodies (aPL). ...Areas covered: This paper discusses all aspects of CAPS, including its pathophy …
Catastrophic antiphospholipid syndrome (CAPS) is a rare, life-threatening disease. In 1992, Asherson defined it as a widespread coagu …
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE. Buyon JP, et al. Ann Intern Med. 2015 Aug 4;163(3):153-63. doi: 10.7326/M14-2235. Ann Intern Med. 2015. PMID: 26098843 Free PMC article.
Severe flares in the second and third trimesters occurred in 2.5% and 3.0%, respectively. Baseline predictors of APOs included presence of lupus anticoagulant (LAC) (odds ratio [OR], 8.32 [CI, 3.59 to 19.26]), antihypertensive use (OR, 7.05 [CI, 3.05 to 16.31 …
Severe flares in the second and third trimesters occurred in 2.5% and 3.0%, respectively. Baseline predictors of APOs included presen …
The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System.
Arreola-Diaz R, Majluf-Cruz A, Sanchez-Torres LE, Hernandez-Juarez J. Arreola-Diaz R, et al. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221088576. doi: 10.1177/10760296221088576. Clin Appl Thromb Hemost. 2022. PMID: 35317658 Free PMC article. Review.
The antiphospholipid syndrome (APS), a systemic autoimmune disease characterized by a hypercoagulability associated to vascular thrombosis and/or obstetric morbidity, is caused by the presence of antiphospholipid antibodies such as lupus anticoagulant, anti-b …
The antiphospholipid syndrome (APS), a systemic autoimmune disease characterized by a hypercoagulability associated to vascular throm …
Systemic lupus erythematosus and menopause.
Gompel A. Gompel A. Climacteric. 2020 Apr;23(2):109-115. doi: 10.1080/13697137.2019.1679113. Epub 2019 Oct 28. Climacteric. 2020. PMID: 31657240 Review.
Estrogen has been known for a long time to be a trigger on auto-immunity and may influence the course of lupus. Women experiencing systemic lupus are at high risk for premature ovarian insufficiency if using cyclophosphamide, of osteoporosis, arterial ischemi …
Estrogen has been known for a long time to be a trigger on auto-immunity and may influence the course of lupus. Women experien …
COVID-19 versus HIT hypercoagulability.
Warkentin TE, Kaatz S. Warkentin TE, et al. Thromb Res. 2020 Dec;196:38-51. doi: 10.1016/j.thromres.2020.08.017. Epub 2020 Aug 10. Thromb Res. 2020. PMID: 32841919 Free PMC article. Review.
Several hematology abnormalities have been observed in COVID-19 patients, including lymphopenia, neutrophilia, thrombocytopenia (usually mild), thrombocytosis, elevated prothrombin time and partial thromboplastin times (the latter abnormality often indicating lupus anti …
Several hematology abnormalities have been observed in COVID-19 patients, including lymphopenia, neutrophilia, thrombocytopenia (usually mil …
Lupus anticoagulant and mortality in patients hospitalized for COVID-19.
Gazzaruso C, Mariani G, Ravetto C, Malinverni L, Tondelli E, Cerrone M, Sala V, Bevilacqua L, Altavilla T, Coppola A, Gallotti P. Gazzaruso C, et al. J Thromb Thrombolysis. 2021 Jul;52(1):85-91. doi: 10.1007/s11239-020-02335-w. Epub 2020 Nov 7. J Thromb Thrombolysis. 2021. PMID: 33159639 Free PMC article.
However, the association between lupus anticoagulant and thrombotic complications in COVID-19 is controversial and no study has specifically evaluated the impact of lupus anticoagulant on mortality. ...Lupus anticoagulant was found in 95 …
However, the association between lupus anticoagulant and thrombotic complications in COVID-19 is controversial and no study ha …
Lupus anticoagulants in children.
Briones M, Abshire T. Briones M, et al. Curr Opin Hematol. 2003 Sep;10(5):375-9. doi: 10.1097/00062752-200309000-00009. Curr Opin Hematol. 2003. PMID: 12913793 Review.
The antiphospholipid antibodies found in this syndrome are directed against a variety of phospholipid binding proteins of which beta2-glycoprotein and prothrombin are considered to be common antigens. Children who present with thrombosis and are positive for lupus antic …
The antiphospholipid antibodies found in this syndrome are directed against a variety of phospholipid binding proteins of which beta2-glycop …
505 results